JHS Svendgaard Laboratories
8.85
-0.15(-1.67%)
Market Cap₹75.76 Cr
PE Ratio-14.59
Company Performance:
1D-1.67%
1M+27.71%
6M-31.18%
1Y-36.74%
5Y-55.84%
View Company Insightsright
More news about JHS Svendgaard Laboratories
01Feb 26
JHS Svendgaard Laboratories Completes Warrant Conversion, Allots 18.02 Lakh Equity Shares
JHS Svendgaard Laboratories Limited completed the conversion of 18,01,801 warrants into equity shares at Rs. 27.75 per share on February 01, 2026. Coeus Global Opportunities Fund received the entire allocation, paying Rs. 3,74,99,983.31 as the balance amount and acquiring a 2.06% stake in the company. The conversion increased the company's paid-up equity share capital to Rs. 87,40,57,670, comprising 8,74,05,767 equity shares of Rs. 10.00 face value each.
 no imag found
14Nov 25
JHS Svendgaard Laboratories Approves 31.30 Lakh Employee Stock Options Under New ESOP Scheme
JHS Svendgaard Laboratories Limited has approved the grant of 31,30,000 employee stock options (ESOPs) under its new Employee Stock Option Scheme-2025. The options have a face value and exercise price of Rs. 10 each, with a grant date of November 14, 2025. The vesting period starts one year from the grant date and extends up to five years, with a maximum exercise period of 5 years from each vesting date. The scheme complies with SEBI regulations and aims to align employee interests with company performance.
 no imag found
22Sept 25
JHS Svendgaard Laboratories Reappoints Nikhil Nanda as Managing Director, Approves Key Appointments
JHS Svendgaard Laboratories Limited held its 21st AGM on September 20, 2025, making several important decisions. Shareholders approved the reappointment of Nikhil Nanda as Managing Director for a five-year term starting July 2, 2025. The company appointed M/s V.K. Khosla & Co as Statutory Auditors and M/s Dahiya & Associates as Secretarial Auditors, both for five-year terms. Mr. Vinay Mittal was appointed as a Director. The JHS Svendgaard Laboratories Limited - Employee Stock Option Scheme 2025 was also approved. Key resolutions, including financial statement adoption, passed with over 99% votes in favor.
 no imag found
1 Year Returns:-36.74%
Industry Peers
Godrej Consumer Products
1,067.10
(-2.11%)
Dabur India
441.50
(-3.18%)
Colgate Palmolive
2,096.20
(-1.70%)
Gillette
7,953.50
(-1.39%)
Emami
444.50
(-2.93%)
Cupid
119.58
(+3.23%)
Mamaearth
340.60
(-1.60%)
Bajaj Consumer Care
450.45
(-2.36%)
Anondita Medicare
999.20
(-2.07%)